EN
HI
Summary
As of 14 Nov, 2026, Novelix Pharmaceuticals stock price is ₹69.12. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Novelix Pharmaceuticals has traded between ₹38.00 and ₹92.00.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹69.12.
Novelix Pharmaceuticals has an upper circuit limit of ₹82.94 and a lower circuit limit of ₹55.30. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Novelix Pharmaceuticals also offers a dividend yield of 0%.
Novelix Pharmaceuticals Share Price Chart
Novelix Pharmaceuticals Share Key Metrics
Volume
0.00
Market Cap
217.94 CR
LTQ@LTP
0@69.12
ATP
0
Var Margin
26.04 %
Circuit Range
55.3-82.94
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Novelix Pharmaceuticals Resistance and Support
Pivot 70.99
Resistance
First Resistance
73.73
Second Resistance
78.34
Third Resistance
81.08
Support
First Support
66.38
Second Support
63.64
Third Support
59.03
Novelix Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 70.24 | 70 | 1.27% | 73.89 | 67.65 |
| Thu Nov 12 2026 | 75.59 | 69.12 | 3.15% | 75.59 | 68.25 |
| Wed Nov 11 2026 | 67.8 | 67.01 | 5.96% | 68.8 | 65.59 |
Novelix Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-11 | Quarterly Results |
| 2026-08-29 | Others |
| 2026-08-13 | Quarterly Results |
| 2026-06-04 | Preferential Issue of shares & Others |
| 2026-05-29 | Audited Results & Preferential issue |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-14 | Quarterly Results & A.G.M. |
| 2025-06-24 | Others |
| 2025-05-27 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results & Others |
| 2024-10-21 | To consider issue of Warrants |
| 2024-10-14 | To consider issue of Warrants |
| 2024-09-02 | Others |
| 2024-08-08 | Quarterly Results |
| 2024-03-05 | Preferential issue of shares |
Novelix Pharmaceuticals News
Novelix Pharmaceuticals Ltd - 536565 - Announcement Under Regulation 30 (LODR)- Supply Agreement
Novelix Pharmaceuticals has entered into a supply agreement with Belgium's axabio NV. The company will procure natural astaxanthin to strengthen its product portfolio, expecting meaningful revenue contribution.
Nov 13 2026 14:47:32
Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, 11Th November, 2026
Novelix Pharmaceuticals reported Q2 FY27 revenue of ₹44.73 crores and net profit of ₹1.56 crores, up 193% YoY. The board also approved the redesignation of Venkateshwarlu Pulluru to Non-Executive Director and the opening of a new corporate office in Gachibowli, Hyderabad.
Nov 11 2026 19:22:48
Read More
Novelix Pharmaceuticals Management
| Name | Position |
|---|---|
| Venkateshwarlu Pulluru | Whole Time Director |
| Janardhan Das Kabra | Non Executive Independent Director |
Novelix Pharmaceuticals FAQs
The Buying Price of Novelix Pharmaceuticals share is 69.12 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novelix Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novelix Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novelix Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novelix Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novelix Pharmaceuticals’s valuation compare Sector P/E, P/B which are 47.36 & 1.71 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novelix Pharmaceuticals is 217.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novelix Pharmaceuticals share price is 92.00 & 38.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novelix Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NOVELIX
